Cite
MLA Citation
C. Tarantelli et al.. “The novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas.” European journal of cancer, vol. 69, n.d., pp. S38–. http://access.bl.uk/ark:/81055/vdc_100039473340.0x00000a
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
C. Tarantelli et al.. “The novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas.” European journal of cancer, vol. 69, n.d., pp. S38–. http://access.bl.uk/ark:/81055/vdc_100039473340.0x00000a